arrow
A

Anthony Turpin

CHU Lille
H指数:26
被引数:2,837

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Adjuvant capecitabine in resected biliary tract cancer: a real-world data from the BILCAP-Real study (ACABi multicentre cohort)
2026-07-280
OA
Netrin1 blockade alleviates resistance to chemotherapy in pancreatic cancer

Netrin1阻断减轻胰腺癌对化疗的耐药性

Nature
IF48.5
2026-04-220
OAAI
Efficacy of targeted therapies for metastatic small bowel adenocarcinoma treatment: a retrospective study by AGEO

靶向疗法治疗转移性小肠腺癌的疗效:AGEO进行的一项回顾性研究

2026-03-280
PRE
Management of biliary tract cancers in elderly patients: a French multicenter retrospective study (PRONOBIL-ACABi)

老年患者胆道肿瘤的管理:一项法国多中心回顾性研究(PRONOBIL-ACABi)

2025-10-030
OA
FOLFIRINOX or FOLFOX for locally advanced or metastatic small bowel adenocarcinoma: PRODIGE 86 – FFCD-GONO – ENGIC 02 – FOLFIRINOX SBA phase II randomized trial

FOLFIRINOX或FOLFOX用于局部晚期或转移性小肠腺癌:PRODIGE 86 – FFCD-GONO – ENGIC 02 – FOLFIRINOX SBA II期随机试验

2025-07-280
OAAI
Deciphering human endogenous retrovirus expression in colorectal cancers: exploratory analysis regarding prognostic value in liver metastases

解读结直肠癌中内源性逆转录病毒的表达:关于肝转移预后价值的探索性分析

2025-06-010
OA
Response to systemic treatments and survival of fibrolamellar carcinomas: An AGEO-SFCE French multicenter retrospective cohort

对纤维层状癌的全身性治疗反应与生存:一项法国AGEO-SFCE多中心回顾性队列研究

2025-05-010
OAAI
Regorafenib combined with irinotecan as second-line treatment in metastatic gastro-oesophageal adenocarcinomas: results of PRODIGE 58-UCGI35-REGIRI Unicancer randomised phase II study

瑞戈非尼联合伊立替康作为转移性胃食管腺癌的二线治疗:PRODIGE 58-UCGI35-REGIRI Unicancer随机II期研究的结果

2025-05-010
OA
Muscle Loss During First-Line Chemotherapy Impairs Survival in Advanced Pancreatic Cancer Despite Adapted Physical Activity

尽管适应性身体活动干预,一线化疗期间的肌肉流失仍会损害晚期胰腺癌患者的生存率

2025-01-170
OAAI
Emergence of Neuroendocrine Tumors in Patients Treated with Androgen Receptor Pathway Inhibitors for Metastatic Prostate Cancer: A Systematic Review and Meta-analysis

雄激素受体通路抑制剂治疗转移性前列腺癌患者中神经内分泌肿瘤的出现:一项系统评价和荟萃分析

2025-01-010
PRE
Association between the antibiotics use and recurrence in patients with resected colorectal cancer: EVADER-1, a nation-wide pharmaco-epidemiologic study

抗生素使用与切除的结直肠癌患者复发之间的关联: EVADER-1,一项全国性的药物流行病学调查

2025-01-010
PRE
Real-life data on biliary tract cancers in France: The nested Amber study from the French ACABi GERCOR PRONOBIL retro-prospective, observational cohort
2025-01-011
OAAI
Induction triplet chemotherapy in patients with rectal adenocarcinoma and synchronous metastases, an AGEO-FFCD study

直肠腺癌伴同步转移患者的诱导三联化疗:一项AGEO-FFCD研究

2025-01-010
OAAI
Relative dose intensity of first-line triplet chemotherapy in metastatic colorectal cancer
2025-01-010
OAAI
Olaparib as maintenance therapy in non resectable pancreatic adenocarcinoma associated with homologous recombination deficiency profile: A French retrospective multicentric AGEO real-world study
2024-11-010
OAAI
PRODIGE 86 (FFCD 2103-GONO) - FOLFIRINOX SBA: Phase II randomized trial to evaluate mFOLFIRINOX and mFOLFOX in the treatment of locally advanced or metastatic small bowel adenocarcinoma

PRODIGE 86 (FFCD 2103-GONO) - FOLFIRINOX SBA:一项II期随机试验,旨在评估mFOLFIRINOX和mFOLFOX方案在局部晚期或转移性小肠腺癌治疗中的效果。

2024-09-010
PRE
Efficacy and safety of the combination of encorafenib/cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: an AGEO real-world multicenter study
2024-09-014
OAAI